Citius Oncology, Inc.
CTOR
$5.22
$0.030.58%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Net Income | -7.74M | -6.66M | -6.81M | -4.77M | -4.84M |
| Total Depreciation and Amortization | -- | -- | -- | -- | -- |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 2.35M | 2.07M | 1.81M | 2.10M | 2.10M |
| Change in Net Operating Assets | 5.38M | 4.59M | 5.13M | 2.67M | 2.73M |
| Cash from Operations | 0.00 | 0.00 | 126.40K | 0.00 | 0.00 |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -5.00M | -- | -- |
| Cash from Investing | -- | -- | -5.00M | -- | -- |
| Total Debt Issued | -- | -- | 3.80M | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | 1.07M | -- | -- |
| Cash from Financing | -- | -- | 4.87M | -- | -- |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -- | -- | 100.00 | -- | -- |